Boltz, backed by a16z and Bessemer, aims to take drug hypotheses to human-ready molecules on a computer

GabriCorso · x · 2026-11-18

Boltz founder GabriCorso thanked its investor lineup, including Bessemer, a16z, Amplify Partners, Zetta Ventures, Obvious Ventures, Greycroft, F Prime, and Benchling. The company's long-term goal: a scientist can go from a therapeutic hypothesis to a human-ready molecule without leaving their computer. The team says much remains to build, but daily progress keeps reinforcing that conviction.

Related event: Boltz's long-term goal: hypothesis to human-ready molecule without leaving the computer(2 posts)→

Original post →

More from Venture

Venture channel →